WHO Issues Concern Over Critical Lack of Weight-Loss Injections
Fewer than one in 10 patients that would benefit from obesity jabs including Wegovy can access them, caution the World Health Organization as it releases its initial recommendations on the drugs.
With more than one billion individuals worldwide currently obese, it is calling for broader and more equitable access to these injectable treatments.
Based on forecasts, in excess of 2,000,000,000 will be obese by 2030 without intervention.
"Our new guidance acknowledges that excess weight is a lifelong illness that can be managed with holistic and ongoing support," stated its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and distribution challenges are key barriers to universal availability to the jabs that can help people shift considerable weight, says the body.
Skinny Jab Scarcity
Despite the current most optimistic scenario, the manufacturing of GLP-1 therapies might only reach approximately 100 million people – fewer than 10% of eligible patients, according to the health organization.
The recommendation urges nations and manufacturers to widen access, via approaches like voluntary licensing.
Exclusive production rights on a key compound – the core component of the drug Wegovy – is scheduled to end in a number of countries in 2026.
How Weight-Loss Injections Function
GLP-1 drugs imitate a biological compound to reduce digestion speed, curb appetite and enhance the sense of being full so users consume fewer calories.
Individuals typically begin shedding pounds after several weeks of commencing the weekly injections.
Research suggests patients may regain a significant portion after a year of stopping the treatment, as their normal food cravings come back.
To be carrying excess weight elevates your chance for developing health problems, such as type 2 diabetes, heart disease, brain attack, and certain cancers.
Excess weight impacts individuals in every country and was linked to 3.7 million fatalities worldwide in 2024, as per the WHO.
